Skip to content
  • 6,799 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started

Presolicitation

10X Genomics, Inc. Reagents for the Critical Care Medicine Departments (CCMD)

24-008747

National Institutes of Health, National Institutes of Health - CC. In-Vitro Diagnostic Substance Manufacturing.

Awarded

10X Genomics, Inc.

$54,974.00 obligated so far on USAspending

Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities

This one was awarded in 2024

13 like it are open now in in-vitro diagnostic substance manufacturing

All 13 open in in-vitro diagnostic substance manufacturing

Description

As published on SAM.gov.

10X Genomics, Inc. Reagents for the Critical Care Medicine Departments (CCMD)

Product Service Code:

6550 NAICS Code:

325413 Place of Performance:

Bethesda, MD 20892 POTS: 24-008747 Description This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.

The National Institutes of Health (NIH), Office of Purchasing and Contracts on behalf of Critical Care Medicine Department (CCMD) intends to award a fixed price contract with a five (5) month base year to 10X Genomics, Inc, Pleasanton, California 94588-3260 on a sole source basis to provide various reagents to use with the Chromium X equipment. The Critical Care Medicine Department (CCMD) is currently working on a research project determining immune mechanisms in controlling responses to Pneumocystis infection.

The project consists of immunocompromised and critically ill patients. Highly sensitive single-cell RNA-seq is a critical technology that will be performed in the Chromium X equipment. The merits of the technology have been validated through consistent studies. Proprietary 10X Genomics, Inc. reagents must be used with existing instrumentation. There are no other known sources that can supply the various reagents.

Using any other reagents not compatible with the Chromium X equipment would potentially damage the equipment and cause erroneous testing results. It is imperative to procure the 10X Genomics reagents to maintain consistency and continuity of the research project in support of patient care. Products Chromium Next GEM reagents, Chromium Next GEM chips, Library Construction Kit, Dual Index Kit, Chromium Single Cell, and other reagents and supplies from 10 x genomics not limited to the above.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.

Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number on the email subject line, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Tasha Lowe, Contract Specialist, lowet2@mail.nih.gov by the due date May 26, 2024 and time marked in this notice.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
D1NLDEZ14TV5
CAGE
7EWK7
Vendor location
Pleasanton, CA
Contract
75N90024P00459, purchase order
Obligated
$54,974.00
Actions
2 between June 14, 2024 and July 15, 2024
Competition
Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Reagents Needed for the Critical Care Medicine Department (Ccmd)
Match
solicitation number 24008747 equals the FPDS solicitation identifier; same awarding office 75N900 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 16, 2024

    Presolicitation

    Due May 26, 2024 at 12:00 PM EDT. SAM.gov, notice d7a40b52b232422eafe170af9eb7206a

Points of contact